Meeting
2012 ASCO Annual Meeting
Progression of genomic signatures in local and metastatic estrogen receptor-positive (ER+) breast cancer: Relevance to palliative treatment.
Authors
William Fraser Symmans
University of Texas M. D. Anderson Cancer Center, Houston, TX
William Fraser Symmans , Eleni Andreopoulou , Daniel J. Booser , Christos Hatzis , Michael J. Wallace , Ya Zhang , Yun Gong , Michail Ignatiadis , Christos Sotiriou , Fabrice Andre , Florentina Peintinger , Peter Regitnig , Christian Marth , Christine Desmedt , Sherene Loi , Stacy L. Moulder , Gabriel N. Hortobagyi , Lajos Pusztai , Vicente Valero
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 30, 2012 (suppl; abstr 515)
DOI
10.1200/jco.2012.30.15_suppl.515
Abstract #
515
Poster Bd #
5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative.
First Author: Elisa Agostinetto
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Prognostication model based on genomic expression in the tumor microenvironment of ER positive, HER2-negative stage III breast cancer via machine learning.
First Author: Yara Abdou
Poster
2011 ASCO Annual Meeting
Hormone therapy versus chemotherapy as first-line treatment for estrogen receptor-positive metastatic breast cancer (MBC) patients.
First Author: T. Y. Chang
Poster
2024 ASCO Breakthrough
Characterization of estrogen receptor mutant breast cancer in 3D cell culture.
First Author: Olivia Mayer